Spectral AI (MDAI) vs Myomo (MYO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Myomo (MYO) has outperformed Spectral AI (MDAI) over the past year, gaining 19.5% versus a loss of 35.2%. Over five years, MDAI leads with a -83.2% price change compared with -89.4% for MYO. Myomo is the larger company by market cap ($56.6 million vs $53.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MDAI | MYO |
|---|---|---|
| Share price | $1.65 | $1.43 |
| Market cap | $53.11M | $56.64M |
| 1-day change | +0.61% | +1.42% |
| YTD return | +15.49% | +54.95% |
| 1-year return | -35.18% | +19.49% |
| 5-year return | -83.20% | -89.43% |
| EPS (TTM) | $-0.32 | $-0.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.97 | $1.89 |
| 52-week low | $1.18 | $0.605 |
| Distance from 52-week high | -44.44% | -24.14% |
| Analyst consensus | none | none |
| Avg. price target upside | +209.70% | +224.48% |
| Average volume | 150.48K | 493.94K |
| Shares outstanding | 32.18M | 39.61M |
| Employees | 65 | 194 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MYO has outperformed MDAI by 54.7 percentage points over the past year.
About Spectral AI
MDAI stock →Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds.
Health Care · Medical/Dental Instruments · 65 employees
About Myomo
MYO stock →Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.
Health Care · Industrial Specialties · 194 employees
MDAI vs MYO FAQ
Which is bigger, Spectral AI or Myomo?
Myomo (MYO) is larger, with a market capitalization of $56.64M compared with $53.11M for Spectral AI (MDAI).
Which stock has performed better over the past year, MDAI or MYO?
MYO returned +19.49% over the past 12 months, compared with -35.18% for MDAI (price return, excluding dividends). Past performance does not predict future results.
Are Spectral AI and Myomo in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Spectral AI and Industrial Specialties for Myomo.